October 28, 2015
October 28, 2015 — St. Jude Medical Inc. announced the company has received CE Mark approval for the HeartMate 3 Left…
October 28, 2015
October 28, 2015 — Stereotaxis Inc. announced the worldwide launch of Respiratory Compensation, a new software feature…
October 27, 2015
October 27, 2015 — A large observational registry found that initial aortic valve replacement (AVR) in asymptomatic…
October 27, 2015
October 27, 2015 — Results from the multicenter, prospective, randomized PANDA III trial indicate that the BuMA…
October 26, 2015
October 26, 2015 — OrbusNeich announced the presentation of the one-year clinical outcomes from the 1,000-patient…
October 26, 2015
October 26, 2015 — Medinol announced in September the completion of enrollment in its BIONICS trial to evaluate the…
October 23, 2015
October 23, 2015 — CardioKinetix Inc. announced that it has received regulatory approval for the Parachute system in…
October 23, 2015
October 23, 2015 — Results of the TUXEDO trial, designed to compare two types of stents in diabetic patients, found…
October 23, 2015
October 23, 2015 — A randomized trial found that ranolazine did not reduce the composite rate of ischemia-driven…
October 22, 2015
October 22, 2015 — Medtronic plc released the first CoreValve transcatheter aortic valve replacement (TAVR) system…
October 22, 2015
October 22, 2015 — Results from the LEADERS FREE trial found that a polymer-free drug-coated stent (DCS) was superior…
October 22, 2015
October 22, 2015 — Results from the ISAR-DESIRE 4 trial indicate that use of a scoring balloon plus a paclitaxel-coated…
October 22, 2015
October 22, 2015 — Direct Flow Medical Inc. announced one-year outcomes from the DISCOVER post-market study that…
October 21, 2015
October 21, 2015 — For the first time, cardiopulmonary resuscitation (CPR) guidelines issued by the American Heart…
October 21, 2015
October 21, 2015 — Bracco Diagnostics Inc. announced that Lumason was approved by the Centers for Medicare and Medicaid…
October 20, 2015
October 20, 2015 — A pair of studies presented at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT)…
October 20, 2015
October 20, 2015 — Results from the BRAVO 3 trial found that bivalirudin did not significantly reduce major bleeding…
October 19, 2015
October 19, 2015 — Vascular Interventional Advances (VIVA) Physicians, a not-for-profit organization dedicated to…
October 19, 2015
October 19, 2015 — The U.S. Food and Drug Administration (FDA) granted accelerated approval to Praxbind (idarucizumab)…
October 19, 2015
There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT)…
